BELLEVUE GROUP AG Cytokinetics, Incorporated Transaction History

BELLEVUE GROUP AG portfolio value:

$3.45M
portfolio value

BELLEVUE GROUP AG quarter portfolio value change:

+23.31%
quarter

Cytokinetics, Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +7.23% 4.8K shares 841K $48.45 71.2K
Q2 2022 share Decrease -3.77% -2.6K shares 69K $39.29 66.4K
Q1 2022 share Increase 0.00% 69K shares 2.54M $36.81 69K